498 related articles for article (PubMed ID: 32097570)
1. Chemical Biology Framework to Illuminate Proteostasis.
Sebastian RM; Shoulders MD
Annu Rev Biochem; 2020 Jun; 89():529-555. PubMed ID: 32097570
[TBL] [Abstract][Full Text] [Related]
2. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
[TBL] [Abstract][Full Text] [Related]
3. How Does the Ribosome Fold the Proteome?
Cassaignau AME; Cabrita LD; Christodoulou J
Annu Rev Biochem; 2020 Jun; 89():389-415. PubMed ID: 32569518
[TBL] [Abstract][Full Text] [Related]
4. Proteostasis impairment in protein-misfolding and -aggregation diseases.
Hipp MS; Park SH; Hartl FU
Trends Cell Biol; 2014 Sep; 24(9):506-14. PubMed ID: 24946960
[TBL] [Abstract][Full Text] [Related]
5. Endoplasmic reticulum proteostasis impairment in aging.
Martínez G; Duran-Aniotz C; Cabral-Miranda F; Vivar JP; Hetz C
Aging Cell; 2017 Aug; 16(4):615-623. PubMed ID: 28436203
[TBL] [Abstract][Full Text] [Related]
6. Small-molecule modulation of cellular chaperones to treat protein misfolding disorders.
Sloan LA; Fillmore MC; Churcher I
Curr Opin Drug Discov Devel; 2009 Sep; 12(5):666-81. PubMed ID: 19736625
[TBL] [Abstract][Full Text] [Related]
7. The Chemical Biology of Molecular Chaperones--Implications for Modulation of Proteostasis.
Brandvold KR; Morimoto RI
J Mol Biol; 2015 Sep; 427(18):2931-47. PubMed ID: 26003923
[TBL] [Abstract][Full Text] [Related]
8. In vivo aspects of protein folding and quality control.
Balchin D; Hayer-Hartl M; Hartl FU
Science; 2016 Jul; 353(6294):aac4354. PubMed ID: 27365453
[TBL] [Abstract][Full Text] [Related]
9. Protein Misfolding Diseases.
Hartl FU
Annu Rev Biochem; 2017 Jun; 86():21-26. PubMed ID: 28441058
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms and Functions of Spatial Protein Quality Control.
Sontag EM; Samant RS; Frydman J
Annu Rev Biochem; 2017 Jun; 86():97-122. PubMed ID: 28489421
[TBL] [Abstract][Full Text] [Related]
11. Proteostasis: bad news and good news from the endoplasmic reticulum.
Noack J; Brambilla Pisoni G; Molinari M
Swiss Med Wkly; 2014; 144():w14001. PubMed ID: 25144910
[TBL] [Abstract][Full Text] [Related]
12. Alpha 1-Antitrypsin Deficiency: A Disorder of Proteostasis-Mediated Protein Folding and Trafficking Pathways.
Karatas E; Bouchecareilh M
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098273
[TBL] [Abstract][Full Text] [Related]
13. A systematic atlas of chaperome deregulation topologies across the human cancer landscape.
Hadizadeh Esfahani A; Sverchkova A; Saez-Rodriguez J; Schuppert AA; Brehme M
PLoS Comput Biol; 2018 Jan; 14(1):e1005890. PubMed ID: 29293508
[TBL] [Abstract][Full Text] [Related]
14. The Proteome Folding Problem and Cellular Proteostasis.
Powers ET; Gierasch LM
J Mol Biol; 2021 Oct; 433(20):167197. PubMed ID: 34391802
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of endoplasmic reticulum-associated degradation rescues native folding in loss of function protein misfolding diseases.
Wang F; Song W; Brancati G; Segatori L
J Biol Chem; 2011 Dec; 286(50):43454-64. PubMed ID: 22006919
[TBL] [Abstract][Full Text] [Related]
16. Quality control of mislocalized and orphan proteins.
Kong KE; Coelho JPL; Feige MJ; Khmelinskii A
Exp Cell Res; 2021 Jun; 403(2):112617. PubMed ID: 33930402
[TBL] [Abstract][Full Text] [Related]
17. Molecular chaperone functions in protein folding and proteostasis.
Kim YE; Hipp MS; Bracher A; Hayer-Hartl M; Hartl FU
Annu Rev Biochem; 2013; 82():323-55. PubMed ID: 23746257
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of protein homeostasis and aggregation.
Laskowska E; Kuczyńska-Wiśnik D; Lipińska B
J Proteomics; 2019 Apr; 198():98-112. PubMed ID: 30529741
[TBL] [Abstract][Full Text] [Related]
19. Chemical and biological approaches for adapting proteostasis to ameliorate protein misfolding and aggregation diseases: progress and prognosis.
Lindquist SL; Kelly JW
Cold Spring Harb Perspect Biol; 2011 Dec; 3(12):. PubMed ID: 21900404
[TBL] [Abstract][Full Text] [Related]
20. Molecular chaperones as therapeutic targets to counteract proteostasis defects.
Cattaneo M; Dominici R; Cardano M; Diaferia G; Rovida E; Biunno I
J Cell Physiol; 2012 Mar; 227(3):1226-34. PubMed ID: 21618531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
